Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:European_Union
|
| gptkbp:ATCCode |
C01EB22
|
| gptkbp:brand |
gptkb:Brinavess
|
| gptkbp:CASNumber |
330942-05-7
|
| gptkbp:chemicalFormula |
C27H37NO4
|
| gptkbp:compatibleWith |
gptkb:United_States
|
| gptkbp:developedBy |
Cardiome Pharma
|
| https://www.w3.org/2000/01/rdf-schema#label |
vernakalant
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
antiarrhythmic
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
nausea
sneezing hypotension bradycardia dysgeusia paresthesia |
| gptkbp:usedFor |
gptkb:atrial_fibrillation
|
| gptkbp:bfsParent |
gptkb:Brinavess
|
| gptkbp:bfsLayer |
6
|